Alterations in the expression of neuronal chloride transporters may contribute to schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 2, 2011, Pages 410-414

  Kalkman, Hans O ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Epilepsy; Neuronal maturation; NKCC1; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BUMETANIDE; BUNGAROTOXIN RECEPTOR; GALANTAMINE; NEUROLEPTIC AGENT; PILOCARPINE; POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; VARENICLINE;

BRAIN MATURATION; CELL PROLIFERATION; CHROMOSOME DELETION; DENDRITE; DISEASE PREDISPOSITION; EPILEPSY; GENE MUTATION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MENTAL DEFICIENCY; NERVE CELL DIFFERENTIATION; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NEURAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEIZURE; SYNAPSE;

AGE FACTORS; ANIMALS; CHLORIDES; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; MICE; NEURAL STEM CELLS; RISK FACTORS; SCHIZOPHRENIA; SEIZURES; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS;

EID: 79952898091     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.01.004     Document Type: Review

References (94)

1. Adachi K., Mirzadeh Z., Sakaguchi M., Yamashita T., Nikolcheva T., Gotoh Y., et al. β-Catenin signaling promotes priliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells 2007, 25:2827-2836.
2. Adams C.E., Broide R.S., Chen Y., Winzer-Serhan U., Henderson T.A., Leslie F.M., et al. Development of the α7 nicotinic cholinergic receptor in rat hippocampal formation. Dev Brain Res 2002, 139:175-187.
3. Agulhon C., Abitbol M., Bertrand D., Malafosse A. Localization of mRNA for CHRNA7 in human fetal brain. Neuroreport 1999, 10:2223-2227.
4. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P.A., Kavvoura F.K., Khoury M.J., et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008, 40:827-834.
5. Ancin I., Barabash A., Vazquez-Alvarez B., Santos J.L., Sanchez-Morla E., Martinez J.L., et al. Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with schizophrenia. Psychiatr Genet 2010, 20:289-297.
6. Arion D., Lewis D.A. Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia. Arch Gen Psychiatr 2011, 68:21-31.
7. Aubert J., Dunstan H., Chambers I., Smith A. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat Biotechnol 2002, 20:1240-1245.
8. Ben-Ari Y., Gaiarsa J.L., Tyzio R., Khazipov R. GABA: A pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 2007, 87:1215-1284.
9. Brandt C., Nozadze M., Heuchert N., Rattka M., Löscher W. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. J Neurosci 2010, 30:8602-8612.
10. Buchanan R.W., Conley R.R., Dickinson D., Ball M.P., Feldman S., Gold J.M., et al. Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiatry 2008, 165:82-89.
11. Cascella N.G., Schretlen D.J., Sawa A. Schizophrenia and epilepsy: is there a shared susceptability?. Neurosci Res 2009, 63:227-235.
12. Cepada C., Andre V.M., Wu N., Yamazaki I., Uzgil B., Vinter H.V., et al. Immature neurons and GABA networks may contribute to epileptogenesis in pediatric cortical dysplasia. Epilepsia 2007, 48(Suppl. 5):79-85.
13. Chenn A., Walsh C.A. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002, 297:365-369.
14. Chubb J.E., Bradsaw N.J., Soares D.C., Porteous D.J., Millar J.K. The DISC locus in psychiatric illness. Mol Psychiatry 2007, 13:36-64.
15. Cohen I., Navarro V., Clemenceau S., Baulac M., Miles R. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 2002, 298:1418-1421.
16. Cui D.H., Jiang K.D., Jiang S.D., Xu Y.F., Yao H. The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia. Mol Psychiatry 2005, 10:669-677.
17. Dean B., Keriakous D., Scarr E., Thomas E.A. Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust NZ J Psychiatry 2007, 41:308-320.
18. Duan X., Chang J.H., Ge S., Faulkner R.L., Lim J.Y., Kitabatake Y., et al. Disrupted-in-schizophrenia 1 regulates integration of newly generated neurons in adult brain. Cell 2007, 130:1146-1158.
19. Dzhala V.I., Talos D.M., Sdrulla D.A., Brumback A.C., Mathews G.C., Benke T.A., et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med 2005, 11:1205-1213.
20. Elliott R.C., Miles M.F., Lowenstein D.H. Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J Neurosci 2003, 23:2218-2227.
21. Elmslie F.V., Rees M., Williamson M.P., Kerr M., Kjeldsen M.J., Pang K.A., et al. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet 1997, 6:1329-1334.
22. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia. Nat Gen 2004, 36:131-137.
23. Falk L., Nordberg A., Steiger Å., Kjaeldgaard A., Hellström-Lindahl E. Higher expression of α7 nicotinic receptors in human fetal compared to adult brain. Dev Brain Res 2003, 142:151-160.
24. Fatemi S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009, 35:528-548.
25. Freedman R., Leonard S. Genetic linkage to schizophrenia at chromosome 15q14. Am J Med Genet 2001, 105B:655-657.
26. Freedman R., Coon H., Myles-Worsley M., Orr-Urteger A., Olincy A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to chromosome 15 locus. Proc Natl Acad Sci USA 1997, 94:587-592.
27. Ganguly K., Schinder A.F., Wong S.T., Poo M. GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell 2001, 105:521-532.
28. Gault J., Hopkins J., Berger R., Drebing C., Logel J., Walton C., et al. Comparison of polymorphisms in the α7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. Am J Med Genet 2003, 123B:39-49.
29. Ge S., Pradhan D.A., Ming G., Song H. GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci 2007, 30:1-8.
30. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005, 10:40-68.
31. Haydar S.N., Dunlop J. Neuronal nicotinic acetylcholine receptors - targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease. Curr Top Med Chem 2010, 10:144-152.
32. Helbig I., Mefford H.C., Sharp A.J., Guipponi M., Fichera M., Franke A., et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009, 41:160-162.
33. Hübner C., Stein V., Hermans-Borgmeyer I., Ballanyi K., Jentsch T. Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron 2001, 30:515-524.
34. Hyde T.M., Weinberger D.R. Seizures and schizophrenia. Schizophr Bull 1997, 23:611-622.
35. Jaaro-Peled H., Hayashi-Takagi A., Seshadri S., Kamiya A., Brandon N.J., Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1 - ErbB4 and DISC1. Trends Neurosci 2009, 32:485-495.
36. Kahle K.T., Staley K.J. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Neurosurg Focus 2008, 25:E22.
37. Kahle K.T., Rinehart J., Lifton R.P. Phosphoregulation of the Na-K-2Cl and K-Cl cotransporters by the WNK kinases. Biochim Biophys Acta 2010, 1802:1150-1158.
38. Kalkman H.O. Altered growth factor signaling pathways as the basis of aberrant stem cell maturation in schizophrenia. Pharmacol Ther 2009, 121:115-122.
39. Kanemoto K., Tsuji T., Kawasaki J. Reexamination of interictal psychoses based on DSMIV psychosis classification and international epilepsy classification. Epilepsia 2001, 42:98-103.
40. Kang T.C., An S.J., Park S.K., Hwang I.K., Yoon D.K., Shin H.S., et al. Changes in Na+ -K+ -Cl- cotransporter immunoreactivity in the gerbil hippocampus following transient ischemia. Neurosci Res 2002, 44:249-254.
41. Kao W.T., Wang Y., Kleinman J.E., Lipska B.K., Hyde T.M., Weinberger D.R., et al. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci 2010, 107:15619-15624.
42. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., et al. Neuregulin 1 transcripts are differentially expressed in schziophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci 2006, 103:6747-6752.
43. Law A.J., Kleinman J.E., Weinberger D.R., Weickert C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 2007, 16:129-141.
44. Levav-Rabkin T., Melamed O., Clarke G., Farber M., Cryan J.F., Dinan T.G., et al. A sensitive period of mice inhibitory system to neonatal GABA enhancement is brain region dependent. Neuropsychopharmacology 2010, 35:1138-1154.
45. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002, 25:409-432.
46. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, Part II: schizophrenia. Am J Hum Genet 2003, 73:34-48.
47. Li X., Zhou J., Chen Z., Chen S., Zhu F., Zhou L. Long-term changes of Na+-K+-Cl- co-transporter 1 (NKCC1) and K+-Cl- cotransporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE). Brain Res 2008, 1221:141-146.
48. Liu Z., Neff R.A., Berg D.K. Sequential interplay of nicotinic and GABAergic signaling guides neuronal development. Science 2006, 314:1610-1613.
49. LoTurco J.J., Owens D.F., Heath M.J., Davis M.B., Kriegelstein A.R. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 1995, 15:1287-1298.
50. Lovestone S., Killick R., Di Forti M., Murray R. Schizophrenia as a GSK-3 dysregulation disorder. Trends Neurosci 2007, 30:142-149.
51. Ma X., Li C., Meng H., Du L., Wang Q., Wang Y., et al. Premorbid tobacco smoking is associated with later age at onset in schizophrenia. Psychiatry Res 2010, 178:461-466.
52. MacDonald A.W., Schulz S.C. What we know: findings that every theory of schizophrenia should explain. Schizophr Bull 2009, 35:493-508.
53. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3β/β-catenin signaling. Cell 2009, 136:1017-1031.
54. Marty S., Berninger B., Carroll P., Thoenen H. GABA-ergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor. Neuron 1996, 16:565-570.
55. Masurel-Paulet A., Andrieux J., Callier P., Cuisset J.M., Le Caignec C., Holder M., et al. Delineation of 15q13.3 microdeletions. Clin Genet 2010, 78:149-161.
56. McCabe B.K., Silveira D.C., Cilio M.R., Cha B.H., Liu X., Sogawa Y., et al. Reduced neurogenesis after neonatal seizures. J Neurosci 2001, 21:2094-2103.
57. Meier E., Jörgensen O.S., Schousboe A. Effect of repeated treatment with γ-aminobutyric acid receptor agonist on postnatal development in rats. J Neurochem 1987, 49:1462-1470.
58. Mihalak K.B., Carroll F.I., Luetje C.W. Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors. Mol Pharmacol 2006, 70:801-805.
59. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. Br Med J Clin Res Ed 1987, 295:681-682.
60. Neubauer B.A., Fiedler B., Himmelein B., Kämpfer F., Lässker U., Schwabe G., et al. Centrotemporal spikes in families with rolandic epilepsy: linkage to chromosome 15q14. Neurology 1998, 51:1608-1612.
61. Ng M.Y.M., Levinson D.F., Faraone S.V., Suarez B.K., DeLisi L.E., Arinami T., et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 2009, 14:774-785.
62. Okabe A., Yokokura M., Toyoda H., Shimizu-Okabe C., Ohno K., Sato K., et al. Changes in chloride homeostasis-regulating gene expressions in the rat hippocapus following amygdala kindling. Brain Res 2003, 990:221-226.
63. Overstreet-Wadiche L.S., Bromberg D.A., Bensen A.L., Westbrook G.L. Seizures accelerate functional integration of adult-generated granule cells. J Neurosci 2006, 26:4095-4103.
64. Palma E., Amici M., Sobrero F., Spinelli G., Di Angelatonio S., Ragozzino D., et al. Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory. Proc Natl Acad Sci USA 2006, 103:8465-8468.
65. Parent J.M., Elliott R.C., Pleasure S.J., Barbero N.M., Lowenstein D.H. Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy. Ann Neurol 2006, 59:81-91.
66. Pedrosa E., Nolan K.A., Stefanescu R., Herscovitz P., Novak T., Zukov I., et al. Analysis of a promotor polymorphism in the SMDF Neuregulin 1 isoform in schizophrenia. Neuropsychobiology 2009, 59:205-212.
67. Perl O., Ilani T., Strous R.D., Lapidus R., Fuchs S. The α7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes. FASEB J 2003, 17:1948-1950.
68. Pfeffer C.K., Stein V., Keating D.J., Maier H., Rinke I., Rudhard Y., et al. NKCC1-dependent GABAergic excitation drives synaptic network maturation during early hippocampal development. J Neurosci 2009, 29:3419-3430.
69. Potkin S.G., Turner J.A., Guffanti G., Lakatos A., Fallon J.H., Nguyen D.D., et al. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull 2009, 35:96-108.
70. Qin P., Xu H., Laursen T.M., Vestergaard M., Mortensen P.B. Risk for schizophrenia and schizophrena-like psychosis among patients with epilepsy: population based cohort study. Br Med J 2005, 331:23.
71. Ross C.A., Margolis R.L., Reading S.A.J., Pletnikov M., Coyle J.T. Neurobiology of schizophrenia. Neuron 2006, 52:139-153.
72. Salokangas R.K., Honkonem T., Stengard E., Koivisto A.M., Hietala J. Cigarette smoking in long-term schizophrenia. Eur Psychiatry 2006, 21:219-223.
73. Sardi S.P., Murti J., Koirola S., Patten B.A., Corfas G. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astogenesis in the developing brain. Cell 2006, 127:185-197.
74. Schmidt-Kastner R., van Os J., Steinbusch H.W.M., Schmitz C. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res 2006, 84:253-271.
75. Schneider A.S., Atluri P., Shen Q., Barnes W., Mah S.J., Stadfelt D., et al. Functional nicotinic acetylcholine receptor expression on stem and progenitor cells of the early embryonic nervous system. Ann NY Acad Sci 2002, 971:135-138.
76. Slater E., Beard A.W. The schizophrenia-like psychoses of epilepsy: I. Psychiatric aspects. Br J Psychiatry 1963, 109:95-112.
77. Smith R.C., Lindenmayer J.P., Davis J.M., Cornwell J., Noth K., Gupta S., et al. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder. Schiz Res 2009, 110:149-155.
78. Stefansson H., Sarginson J., Kong A., Yates P., Steinthorsdottir V., Gudfinnsson E., et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003, 72:83-87.
79. Stein V., Hermans-Borgmeyer I., Jentsch T.J., Hübner C.A. Expression of the KCl cotransporter KCC2 parallels neuronal maturation and emergence of low intracellular chloride. J Comp Neurol 2004, 468:57-64.
80. Straub R.E., Weinberger D.R. Schizophrenia genes - famine to feast. Biol Psychiatry 2006, 60:81-83.
81. Tekgul H., Gauvreau K., Murphy L., Robertson R., Stewart J., Volpe J., et al. The current etiological profile and neurodevelopmental outcome of seizures in term born infants. Pediatrics 2006, 117:1270-1280.
82. The International Schizophrenia Consortium Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.
83. Tozuka Y., Fukuda S., Namba T., Seki T., Hisatsune T. GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron 2005, 47:803-815.
84. Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry 2000, 47:210-220.
85. Tyzio R., Holmes G.L., Ben-Ari Y., Khazipov R. Timing of the developmental switch in GABAA mediated signaling from excitation to inhibition in CA3 rat hippocampus using gramidin perforated patch and extracellular recordings. Epilepsia 2007, 48(Suppl. 5):96-105.
86. Vassos E., Collier D.A., Holden S., Patch C., Rajescu D., St Clair D., et al. Penetrance for copy number variants associated with schizophrenia. Hum Mol Genet 2010, 19:3477-3481.
87. Verani R., Cappuccio I., Spinsanti P., Gradini R., Caruso A., Magnotti M.V., et al. Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoid acid. J Neurochem 2007, 100:242-250.
88. Vestergaard M., Pedersen C.B., Chistensen J., Madsen K.M., Olsen J., Mortensen P.B. Febrile seizures and risk of schizophrenia. Schizophr Res 2005, 73:343-349.
89. Waldo M.C., Woodward L., Adler L.E. Varenicline and P50 auditory gating in medicated schizophrenic patients: a pilot study. Psychiatr Res 2010, 175:179-180.
90. Weinberger D.R. On the plausibility of the "neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology 1996, 14:1-11. (Suppl.).
91. Welham J., Isohanni M., Jones P., McGrath J. The antecedents of schizophrenia: a review of birth cohort studies. Schizophr Bull 2009, 35:603-623.
92. Woodhead G.J., Mutch C.A., Olson E.C., Chenn A. Cell-autonomous β-catenin signaling regulates cortical precursor proliferation. J Neurosci 2006, 26:12620-12630.
93. Yamada J., Okabe A., Toyoda H., Kilb W., Luhmann H.J., Fukada A. Cl- uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1. J Physiol 2004, 557:829-841.
94. Zammit S., Allebeck P., Dalman C., Lundberg I., Hemmingsson T., Lewis G. Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiatry 2003, 160:2216-2221.